Boryung Corporation (KRX:003850)

South Korea · Delayed Price · Currency is KRW

9,730.00

+330.00 (3.51%)

Apr 8, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing and Sales			859.63B	760.48B	627.28B	561.87B	524.27B
Pharmaceutical Manufacturing and Sales Growth			13.04%	21.23%	11.64%	7.17%	13.87%
Total			859.63B	760.48B	627.28B	561.87B	524.27B
Total Growth			13.04%	21.23%	11.64%	7.17%	13.87%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
The Republic of Korea			892.26B	796.35B	657.47B	576.94B	524.27B
The Republic of Korea Growth			12.04%	21.12%	13.96%	10.05%	13.87%
Asia			608.24M	487.02M	-	-	-
Asia Growth			24.89%	-	-	-	-
The Adjustments and Removal			-34.53B	-	-	-	-
North America			1.29B	1.81B	1.03B	235.41M	-
North America Growth			-28.93%	75.30%	339.41%	-	-
Internal Sales			-	-38.18B	-31.23B	-15.31B	-
Total			859.63B	760.48B	627.28B	561.87B	524.27B
Total Growth			13.04%	21.23%	11.64%	7.17%	13.87%

Source: S&P Global Market Intelligence.